Cargando…

miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer

MicroRNAs (miRNAs) are non-coding small RNAs that function as negative regulators of gene expression involving in the tumor biology. ATP citrate lyase (ACLY), a key enzyme initiating de novo lipid synthesis, has been found to be upregulated in cancer cells, and its inhibition causes suppressive effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Xin, Mei, Qiao, Zhiguang, Li, Jing, Liu, Jianjun, Song, Shaoli, Zhao, Xiaoping, Miao, Ping, Tang, Tingting, Wang, Lei, Liu, Weichun, Yang, Xiaodi, Dai, Kerong, Huang, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190093/
https://www.ncbi.nlm.nih.gov/pubmed/27317765
http://dx.doi.org/10.18632/oncotarget.10020
_version_ 1782487350529490944
author Xin, Mei
Qiao, Zhiguang
Li, Jing
Liu, Jianjun
Song, Shaoli
Zhao, Xiaoping
Miao, Ping
Tang, Tingting
Wang, Lei
Liu, Weichun
Yang, Xiaodi
Dai, Kerong
Huang, Gang
author_facet Xin, Mei
Qiao, Zhiguang
Li, Jing
Liu, Jianjun
Song, Shaoli
Zhao, Xiaoping
Miao, Ping
Tang, Tingting
Wang, Lei
Liu, Weichun
Yang, Xiaodi
Dai, Kerong
Huang, Gang
author_sort Xin, Mei
collection PubMed
description MicroRNAs (miRNAs) are non-coding small RNAs that function as negative regulators of gene expression involving in the tumor biology. ATP citrate lyase (ACLY), a key enzyme initiating de novo lipid synthesis, has been found to be upregulated in cancer cells, and its inhibition causes suppressive effects in a variety of tumors. At present, although several ACLY inhibitors have been reported, the potential role of miRNAs in interfering ACLY still needs further clarification. Herein, four different types of tumor cells including osteosarcoma, prostate, cervical and lung cancers were adopted in our study, and we have demonstrated that miR-22 directly downregulated ACLY. Moreover, miR-22 was proved to attenuate cancer cell proliferation and invasion, as well as promote cell apoptosis via inhibiting ACLY. Additionally, we confirmed the higher ACLY protein levels and the lower miR-22 expressions in hundreds of clinical samples of the four primary tumors, and a negative correlation relationship between ACLY and miR-22 was clarified. Finally, in the four animal models, we found that along with the loss of the ACLY expression, the miR-22-treated mice developed rather smaller tumors, less probabilities of distant metastasis, and fairly longer survivals. De novo lipogenesis suppression triggered by miR-22-ACLY axis may contribute to the inhibition of tumor growth and metastasis. These findings provide unequivocal proofs that miR-22 is responsible for the posttranscriptional regulation of ACLY, which yields promising therapeutic effects in osteosarcoma, prostate, cervical and lung cancers.
format Online
Article
Text
id pubmed-5190093
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-51900932017-01-05 miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer Xin, Mei Qiao, Zhiguang Li, Jing Liu, Jianjun Song, Shaoli Zhao, Xiaoping Miao, Ping Tang, Tingting Wang, Lei Liu, Weichun Yang, Xiaodi Dai, Kerong Huang, Gang Oncotarget Research Paper MicroRNAs (miRNAs) are non-coding small RNAs that function as negative regulators of gene expression involving in the tumor biology. ATP citrate lyase (ACLY), a key enzyme initiating de novo lipid synthesis, has been found to be upregulated in cancer cells, and its inhibition causes suppressive effects in a variety of tumors. At present, although several ACLY inhibitors have been reported, the potential role of miRNAs in interfering ACLY still needs further clarification. Herein, four different types of tumor cells including osteosarcoma, prostate, cervical and lung cancers were adopted in our study, and we have demonstrated that miR-22 directly downregulated ACLY. Moreover, miR-22 was proved to attenuate cancer cell proliferation and invasion, as well as promote cell apoptosis via inhibiting ACLY. Additionally, we confirmed the higher ACLY protein levels and the lower miR-22 expressions in hundreds of clinical samples of the four primary tumors, and a negative correlation relationship between ACLY and miR-22 was clarified. Finally, in the four animal models, we found that along with the loss of the ACLY expression, the miR-22-treated mice developed rather smaller tumors, less probabilities of distant metastasis, and fairly longer survivals. De novo lipogenesis suppression triggered by miR-22-ACLY axis may contribute to the inhibition of tumor growth and metastasis. These findings provide unequivocal proofs that miR-22 is responsible for the posttranscriptional regulation of ACLY, which yields promising therapeutic effects in osteosarcoma, prostate, cervical and lung cancers. Impact Journals LLC 2016-06-14 /pmc/articles/PMC5190093/ /pubmed/27317765 http://dx.doi.org/10.18632/oncotarget.10020 Text en Copyright: © 2016 Xin et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Xin, Mei
Qiao, Zhiguang
Li, Jing
Liu, Jianjun
Song, Shaoli
Zhao, Xiaoping
Miao, Ping
Tang, Tingting
Wang, Lei
Liu, Weichun
Yang, Xiaodi
Dai, Kerong
Huang, Gang
miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer
title miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer
title_full miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer
title_fullStr miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer
title_full_unstemmed miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer
title_short miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer
title_sort mir-22 inhibits tumor growth and metastasis by targeting atp citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190093/
https://www.ncbi.nlm.nih.gov/pubmed/27317765
http://dx.doi.org/10.18632/oncotarget.10020
work_keys_str_mv AT xinmei mir22inhibitstumorgrowthandmetastasisbytargetingatpcitratelyaseevidenceinosteosarcomaprostatecancercervicalcancerandlungcancer
AT qiaozhiguang mir22inhibitstumorgrowthandmetastasisbytargetingatpcitratelyaseevidenceinosteosarcomaprostatecancercervicalcancerandlungcancer
AT lijing mir22inhibitstumorgrowthandmetastasisbytargetingatpcitratelyaseevidenceinosteosarcomaprostatecancercervicalcancerandlungcancer
AT liujianjun mir22inhibitstumorgrowthandmetastasisbytargetingatpcitratelyaseevidenceinosteosarcomaprostatecancercervicalcancerandlungcancer
AT songshaoli mir22inhibitstumorgrowthandmetastasisbytargetingatpcitratelyaseevidenceinosteosarcomaprostatecancercervicalcancerandlungcancer
AT zhaoxiaoping mir22inhibitstumorgrowthandmetastasisbytargetingatpcitratelyaseevidenceinosteosarcomaprostatecancercervicalcancerandlungcancer
AT miaoping mir22inhibitstumorgrowthandmetastasisbytargetingatpcitratelyaseevidenceinosteosarcomaprostatecancercervicalcancerandlungcancer
AT tangtingting mir22inhibitstumorgrowthandmetastasisbytargetingatpcitratelyaseevidenceinosteosarcomaprostatecancercervicalcancerandlungcancer
AT wanglei mir22inhibitstumorgrowthandmetastasisbytargetingatpcitratelyaseevidenceinosteosarcomaprostatecancercervicalcancerandlungcancer
AT liuweichun mir22inhibitstumorgrowthandmetastasisbytargetingatpcitratelyaseevidenceinosteosarcomaprostatecancercervicalcancerandlungcancer
AT yangxiaodi mir22inhibitstumorgrowthandmetastasisbytargetingatpcitratelyaseevidenceinosteosarcomaprostatecancercervicalcancerandlungcancer
AT daikerong mir22inhibitstumorgrowthandmetastasisbytargetingatpcitratelyaseevidenceinosteosarcomaprostatecancercervicalcancerandlungcancer
AT huanggang mir22inhibitstumorgrowthandmetastasisbytargetingatpcitratelyaseevidenceinosteosarcomaprostatecancercervicalcancerandlungcancer